Gastric (stomach) cancer remains a significant health challenge worldwide. While advancements in chemotherapy and immunotherapy have improved outcomes, researchers are increasingly looking toward $\beta$-Glucan—a natural biological response modifier—as a potent ally to enhance treatment efficacy and patient survival.
What is $\beta$-Glucan?
$\beta$-Glucans are complex polysaccharides found in the cell walls of fungi (like Shiitake mushrooms), yeast, and cereal grains. In countries like Japan, specific forms such as Lentinan have been approved for decades as supportive therapy for gastric cancer due to their unique ability to “re-awaken” the host’s immune system.
How It Transforms Gastric Cancer Treatment
Recent clinical data and molecular research highlight several ways $\beta$-Glucan supports patients:
1. Prolonging Survival in Advanced Cases
Clinical studies have demonstrated that combining $\beta$-glucan (specifically Lentinan) with standard chemotherapy significantly prolongs the overall survival of patients with advanced or recurrent gastric cancer compared to chemotherapy alone. It works by bridging the gap between innate and adaptive immunity.
2. Enhancing Immunotherapy (The Adjuvant Effect)
$\beta$-Glucan is a powerful “adjuvant” in immunotherapy.
Synergy with Checkpoint Inhibitors: New research shows that when combined with drugs like Camrelizumab (a PD-1 inhibitor), $\beta$-glucan can help “warm up” the tumor microenvironment, making the cancer more recognizable to the immune system.
Macrophage Polarization: It helps shift the immune cells within the tumor from a “pro-cancer” state (M2) to an “anti-cancer” state (M1), actively suppressing tumor growth.
3. Boosting the Efficacy of Targeted Antibodies
For patients with HER2-positive gastric cancer, treatments like Trastuzumab are common. $\beta$-Glucan can act synergistically with these monoclonal antibodies by activating complement receptors on immune cells, leading to more effective destruction of cancer cells through a process called antibody-dependent cellular cytotoxicity (ADCC).
A Natural Shield for the Modern Patient
$\beta$-Glucan represents the perfect intersection of nature and science. By modulating the immune system rather than attacking the body, it offers a way to strengthen the patient from within. As we move toward more personalized oncology, $\beta$-glucan stands out as a safe, evidence-based supplement to the “gold standard” of gastric cancer care.
Disclaimer: Always consult with your oncology specialist before introducing new supplements into your treatment plan.
Research Sources:
Ina, K., et al. (2013). “The Use of Lentinan for Treating Gastric Cancer.” Anti-Cancer Agents in Medicinal Chemistry, 13(5), 681-688.
Chu, Y., et al. (2024). “An exploratory clinical study of $\beta$-glucan combined with camrelizumab and SOX chemotherapy as first-line treatment for advanced gastric adenocarcinoma.” Frontiers in Immunology, 15:1448485.
Wang, M., et al. (2024). “$\beta$-glucan: a potent adjuvant in immunotherapy for digestive tract tumors.” Frontiers in Immunology, 15:1424261.
Geller, A., et al. (2019). “Yeast-Derived $\beta$-Glucan in Cancer: Novel Uses of a Traditional Therapeutic.” International Journal of Molecular Sciences, 20(15), 3618.
